ClinicalTrials.Veeva

Menu

Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Sickle Cell Thalassemia
Sickle Cell Anemia

Treatments

Other: Observational

Study type

Observational

Funder types

Other

Identifiers

NCT00736060
0027-08-EMC

Details and patient eligibility

About

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

Full description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.

The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: All patients admitted with fever as the only presenting symptom.

Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Trial design

60 participants in 2 patient groups

1
Description:
Sickle cell anemia
Treatment:
Other: Observational
2
Description:
Sickle cell thalassemia
Treatment:
Other: Observational

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems